Drug Enforcement Administration 2011 – Federal Register Recent Federal Regulation Documents

Results 201 - 250 of 289
Beau Boshers, M.D.; Decision and Order
Document Number: 2011-9172
Type: Notice
Date: 2011-04-15
Agency: Drug Enforcement Administration, Department of Justice
Jacobo Dreszer, M.D.; Decision and Order
Document Number: 2011-9171
Type: Notice
Date: 2011-04-15
Agency: Drug Enforcement Administration, Department of Justice
Cynthia M. Cadet, M.D.; Decision and Order
Document Number: 2011-9170
Type: Notice
Date: 2011-04-15
Agency: Drug Enforcement Administration, Department of Justice
Self-Certification and Employee Training of Mail-Order Distributors of Scheduled Listed Chemical Products
Document Number: 2011-9016
Type: Rule
Date: 2011-04-13
Agency: Drug Enforcement Administration, Department of Justice
On October 12, 2010, the President signed the Combat Methamphetamine Enhancement Act of 2010 (MEA). It establishes new requirements for mail-order distributors of scheduled listed chemical products. Mail-order distributors must now self-certify to DEA in order to sell scheduled listed chemical products at retail. Sales at retail are those sales intended for personal use; mail-order distributors that sell scheduled listed chemical products not intended for personal use, e.g., sale to a university, are not affected by the new law. This self- certification must include a statement that the mail-order distributor understands each of the requirements that apply under part 1314 and agrees to comply with these requirements. Additionally, mail-order distributors are now required to train their employees prior to self certification. DEA is promulgating this rule to incorporate the statutory provisions and make its regulations consistent with the new requirements and other existing regulations related to self-certification.
Glenn D. Krieger, M.D.; Denial of Application
Document Number: 2011-8546
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Clifton D. Burt, M.D.; Revocation of Registration
Document Number: 2011-8545
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Robert Charles Ley, D.O. ; Dismissal of Proceeding
Document Number: 2011-8544
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Alan H. Olefsky, M.D.; Denial of Application
Document Number: 2011-8543
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
The Medicine Dropper; Revocation of Registration
Document Number: 2011-8542
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Louisiana All Snax, Inc.; Dismissal of Proceeding
Document Number: 2011-8541
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Four Seasons Distributors, Inc.; Order Accepting Settlement Agreement and Terminating Proceeding
Document Number: 2011-8537
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Mark De La Lama, P.A.; Denial of Application
Document Number: 2011-8536
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Layfe Robert Anthony, M.D.; Denial of Application
Document Number: 2011-8535
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Calvin Ramsey, M.D.; Revocation of Registration
Document Number: 2011-8533
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Thomas E. Mitchell, M.D.; Dismissal of Proceeding
Document Number: 2011-8531
Type: Notice
Date: 2011-04-11
Agency: Drug Enforcement Administration, Department of Justice
Michael J. Aruta, M.D.; Decision and Order
Document Number: 2011-8348
Type: Notice
Date: 2011-04-07
Agency: Drug Enforcement Administration, Department of Justice
Roni Dreszer, M.D.; Decision and Order
Document Number: 2011-8345
Type: Notice
Date: 2011-04-07
Agency: Drug Enforcement Administration, Department of Justice
Beau Boshers, M.D.; Decision and Order
Document Number: 2011-8344
Type: Notice
Date: 2011-04-07
Agency: Drug Enforcement Administration, Department of Justice
Cynthia M. Cadet, M.D.; Decision and Order
Document Number: 2011-8342
Type: Notice
Date: 2011-04-07
Agency: Drug Enforcement Administration, Department of Justice
Jacobo Dreszer, M.D., Decision and Order
Document Number: 2011-8340
Type: Notice
Date: 2011-04-07
Agency: Drug Enforcement Administration, Department of Justice
Control of Ergocristine, a Chemical Precursor Used in the Illicit Manufacture of Lysergic Acid Diethylamide, as a List I Chemical
Document Number: 2011-7548
Type: Rule
Date: 2011-03-31
Agency: Drug Enforcement Administration, Department of Justice
This rulemaking finalizes a February 24, 2010, Notice of Proposed Rulemaking in which DEA proposed to control the chemical precursor ergocristine as a List I chemical under the Controlled Substances Act (CSA). Clandestine laboratories are using this chemical as a substitute for the List I chemicals ergotamine and ergonovine to illicitly manufacture the schedule I controlled substance lysergic acid diethylamide (LSD). This rule is being finalized as proposed. Therefore, handlers of ergocristine shall be subject to the chemical regulatory provisions of the CSA and its implementing regulations. This rulemaking does not establish a threshold for domestic and international transactions of ergocristine. As such, all transactions involving ergocristine, regardless of size, shall be regulated. This rulemaking also specifies that chemical mixtures containing ergocristine will not be exempt from regulatory requirements at any concentration. Therefore, all transactions of chemical mixtures containing any quantity of ergocristine shall be regulated and subject to control under the CSA.
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-7547
Type: Notice
Date: 2011-03-31
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2011-7545
Type: Notice
Date: 2011-03-31
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2011-7544
Type: Notice
Date: 2011-03-31
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2011-7542
Type: Notice
Date: 2011-03-31
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-7540
Type: Notice
Date: 2011-03-31
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-7539
Type: Notice
Date: 2011-03-31
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2011-7537
Type: Notice
Date: 2011-03-31
Agency: Drug Enforcement Administration, Department of Justice
Roger A. Pellmann, M.D.; Revocation of Registration
Document Number: 2011-7411
Type: Notice
Date: 2011-03-30
Agency: Drug Enforcement Administration, Department of Justice
Bienvenido Tan, M.D.; Denial of Application
Document Number: 2011-7394
Type: Notice
Date: 2011-03-30
Agency: Drug Enforcement Administration, Department of Justice
Scott C. Bickman, M.D.; Revocation of Registration
Document Number: 2011-7393
Type: Notice
Date: 2011-03-30
Agency: Drug Enforcement Administration, Department of Justice
Alfred E. Boyce, M.D.; Decision and Order
Document Number: 2011-7390
Type: Notice
Date: 2011-03-30
Agency: Drug Enforcement Administration, Department of Justice
Erwin E. Feldman, D.O.; Revocation of Registration
Document Number: 2011-7047
Type: Notice
Date: 2011-03-25
Agency: Drug Enforcement Administration, Department of Justice
Gregory F. Saric, M.D.; Decision and Order
Document Number: 2011-7016
Type: Notice
Date: 2011-03-25
Agency: Drug Enforcement Administration, Department of Justice
Robert L. Dougherty, M.D.; Denial of Application
Document Number: 2011-7014
Type: Notice
Date: 2011-03-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2011-6166
Type: Notice
Date: 2011-03-17
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2011-6165
Type: Notice
Date: 2011-03-17
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2011-6164
Type: Notice
Date: 2011-03-17
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-6163
Type: Notice
Date: 2011-03-17
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2011-6157
Type: Notice
Date: 2011-03-17
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2011-6156
Type: Notice
Date: 2011-03-17
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-6155
Type: Notice
Date: 2011-03-17
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: C1-2011-3945
Type: Notice
Date: 2011-03-04
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids Into Schedule I
Document Number: 2011-4428
Type: Rule
Date: 2011-03-01
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily place five synthetic cannabinoids into the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions. The substances are 1-pentyl-3-(1- naphthoyl)indole (JWH-018), 1-butyl-3-(1-naphthoyl)indole (JWH-073), 1- [2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200), 5-(1,1- dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497), and 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol; CP-47,497 C8 homologue). This action is based on a finding by the Administrator that the placement of these synthetic cannabinoids into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the full effect of the CSA and its implementing regulations including criminal, civil and administrative penalties, sanctions and regulatory controls of Schedule I substances will be imposed on the manufacture, distribution, possession, importation, and exportation of these synthetic cannabinoids.
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 2011-4067
Type: Notice
Date: 2011-02-24
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.